G1 THERAPEUTICS, INC. Interest Expense on Debt
G1 THERAPEUTICS, INC. reported Interest Expense on Debt of $4.70 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Expense Statement
us-gaap:InterestExpenseDebt · last filed 2024-08-08
- G1 THERAPEUTICS, INC. interest expense, debt for the quarter ending 2024-06-30 was $4.70M, a 74.07% increase year-over-year.
- G1 THERAPEUTICS, INC. interest expense, debt for the quarter ending 2024-03-31 was $2.00M, a 35.48% decline year-over-year.
- G1 THERAPEUTICS, INC. interest expense, debt for the quarter ending 2023-06-30 was $2.70M.
- G1 THERAPEUTICS, INC. interest expense, debt for the quarter ending 2023-03-31 was $3.10M.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 9 month |
|---|---|---|---|
| 2024-06-30 | $4.70M 10-Q · filed 2024-08-08 | $6.70M derived: sum of 2 quarters · filed 2024-08-08 | |
| 2024-03-31 | $2.00M 10-Q · filed 2024-05-01 | ||
| 2023-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $5.80M 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $3.10M 10-Q · filed 2024-05-01 | ||
| 2022-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $7.40M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $4.70M 10-Q · filed 2022-08-03 |